MDLinxThe Military’s New Testosterone Policy Has Doctors Asking: Who Will Manage the Fallout?

⚖️ Legal / Ethical Complexity

A new Defense Department policy could create one of the largest organized testosterone-screening programs in the United States. The initiative has prompted concerns about overdiagnosis, follow-up capacity, and adherence to established hypogonadism guidelines.

Professional Impact

• Current endocrine and urologic guidelines generally require symptoms plus confirmed low morning testosterone before diagnosing deficiency.
• Population-wide screening may identify asymptomatic biochemical abnormalities that do not represent clinically significant hypogonadism.
• Testosterone replacement therapy requires ongoing monitoring for adverse effects and treatment-related complications.
• Growing public attention may increase patient requests for testosterone testing in nonmilitary practice settings.

Action Items

• Review current diagnostic criteria for testosterone deficiency.
• Evaluate symptoms alongside laboratory findings before labeling hypogonadism.
• Monitor patient questions related to testosterone optimization and screening.
• Document evidence-based indications when discussing testosterone testing.